BEKIR TANRIOVER, M.D.
Curriculum Vitae
MAILING ADDRESS
323 Maple Street
Richardson, TX 75081
Cell Phone: (214) 597-7918
drtanriover@gmail.com
CITIZENSHIP
Turkey and the United States of America
DATE OF BIRTH
09/10/1969
MARITAL STATUS
Married
EDUCATION
07/03 to 06/04
Vanderbilt University
Nashville, TN
Renal Transplantation Fellowship
10/98 to 12/00
University of Alabama at Birmingham
Birmingham, AL
Nephrology Fellowship
10/95 to 09/98
Tulane University Medical School
New Orleans, LA
Internal Medicine Internship/Residency
06/94 to 09/95
Hacettepe University Medical School
Ankara, Turkey
Clinical Microbiology and Infectious Diseases Residency
09/86 to 07/93
Hacettepe University Faculty of Medicine
Ankara, Turkey
Medical Doctor
Revised 9/9/08
Bekir Tanriover, M.D.
Curriculum Vitae
Page 2
EXPERIENCE
07/04 to Present
Dallas Nephrology Associates
Nephrology/Transplantation
Dallas, TX
07/01 to 04/03
ICU Nephrology Consultant
Istanbul Memorial Hospital
Istanbul – Turkey
APPOINTMENTS 01/09 to 01/2013
COMMITTEES
NephSAP Reviewer
American Society of Nephrology
05/07 to Present
Medical Director for Pancreas and
Combined-Kidney/Pancreas Transplantation
Methodist Dallas Medical Center
10/05 to 08/07
Novartis Advisory Board for ERLUS02 Study
08/04 to Present
Clinical instructor for Nephrology Fellows (UTSW),
Internal Medicine Residents (MDMC), Nurse Practioners
(UTA)
10/07 to present
PCAR Committee
Methodist Dallas Medical Center
02/05 to present
Liver Transplant Selection Committee
Methodist Dallas Medical Center
08/04 to present
Kidney Transplant Selection Committee
Methodist Dallas Medical Center
Bekir Tanriover, M.D.
Curriculum Vitae
Page 3
PUBLICATIONS
1)
Tanriover B, Mejia A, Foster SV, Mubarak A. Primary Hyperoxaluria Involving Liver and
Hepatic Artery: Images of an Aggressive Disease. (Considered for the publication after the
completion of the revision at the journal of “Nephrology Dialysis and Transplantation”).
2)
Tanriover B, Wright S, Foster S, Roush K, Castillo-Lugo J, Fa K, Levy F, Mejia A. High-Dose
Intravenous Immunoglobulin and Rituximab Treatment for Antibody Mediated Rejection after
Kidney Transplantation and a Cost Analysis. Transplantation Proceedings 2008, 40 (10): 33933396.
3)
Tanriover B, Mejia A, Weinstein J, Foster S, Ghalib R, Mubarak A, Cheng S. A New Look to
Combined Liver Kidney Allocation in the Post-MELD Era with Kidney Biopsy and GFR
Measurement. Transplantation 2008: 86 (11):1548-53.
4)
Wright S, Shaikh ZHA, Castillo-Lugo J, Tanriover B. Aseptic meningitis and abducens nerve
palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with
renal transplantation. Case Report. Transplant Infectious Disease 2008, 10(4):294-7.
5)
Bolin P, Tanriover B, Zibari G, Lynn M, Pirsch J, Chan L, Cooper M, Langone A, Tomlanovich
S. Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms after Conversion from
Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients.
Transplantation 2007; 84:1443-1451.
6)
Tanriover B, Chuang P, Fishbach B, Helderman J, Kizilisik T, Nylander W, Shaffer D and
Langone A. Polyclonal Antibody-Induced Serum Sickness in Renal Transplant Recipients:
Treatment with Therapeutic Plasma Exchange. Transplantation 2005; 80:279-281.
7)
Ramanathan V, Goral S, Tanriover B, Feurer I, Kazancioglu R, Shaffer D, Helderman J.
Screening Asymptomatic Diabetic Patients for Coronary Artery Disease Prior to Renal
Transplantation. Transplantation 2005; 10:1453-1458, 2005.
8)
H. Arbatlı, E. Demirsoy, O. Yılmaz, M. Ünal, N. Yağan, M. Arpaz, B. Tanriover, F. Tükenmez,
B. Sönmez. Outcomes of CABG Surgery in 17 Patients With ESRD. Turkish Journal of
Dialysis Transplantation and Burn 2003;14(3) 177-182.
9)
Tanriover B, Carlton D, Allon M. Bacteremia Associated with Tunneled Dialysis Catheters:
Comparison of Two Treatment Strategies. Kidney Int 2000; 57:2151-55.
Bekir Tanriover, M.D.
Curriculum Vitae
Page 4
10)
Tanriover B, Tuncer S. Human Immunodeficiency Virus and its Genetics. Turkish Journal of
Biology 1997; 21:505-514.
11)
Taniyuksel M, Erguven S, Tanriover B. Comparison of the Serologic Tests (IFA, ELISA) with
Microscopy Use for the Diagnosis of Amoebosis. Turkish Journal of Parasitology 1995
19(4):476-482.
12)
Tanriover B. The Role of the Helicobacter pylori in the Pathogenesis of Gastric Lymphoma.
Turkish Journal of Hematology and Oncology 1995: 5(1):44-47.
Bekir Tanriover, M.D.
Curriculum Vitae
Page 5
ABSTRACTS
1)
Tanriover B, Wright S. High Dose IVIG and Anti-CD20 Antibody for Antibody Mediated
Rejection Treatment without Plasmapheresis. AST Winter Meeting, Banff, Canada, March 2009.
2)
Tanriover B, Wright S, Foster S, Roush K, Castillo-Lugo J, Fa K, Levy F, Mejia A. Outcome
of Antibody Mediated Rejection Treatment with High Dose IVIG and Anti-CD20 Antibody. Am
J Transpl 8 Suppl. 2:580, April 2008.
3)
Tanriover B, Mejia A, Weinstein J, Foster S, Ghalib R, Mubarak A, Cheng S. Analysis of
Renal Function Assessment and Renal Biopsy Data in Liver Failure Patients with Renal
Dysfunction. A New Look to Combined Liver Kidney Transplantation Work up Algorithm;
Single Center Experience. Am J Transpl 8 Suppl. 2:337, April 2008.
4)
Friedman, D, Rashdan, S, Levine, C, Weinstein, J, Schwartz, A., Tanriover, B, Ghalib, R.
Efficacy and Safety of Peg IFN alfa-2a and Low Dose Ribavirin in ESRD Patients with Hepatitis
C. Digestive Disease Week, Washington, DC, May 2007.
5)
Tomlanovich S, Bolin P, Tanriover B. A Three-Month, Prospective, Open-Label, Two Cohort
Study to Investigate the Efficacy, Safety and Tolerability of EC-MPS in Combination with
Cyclosporin or Tacrolimus in Renal Transplant Recipients With GI Intolerance. Am J Transpl 6
Suppl. 2:487, August 2006.
6)
Bolin P, Tanriover B, Lynn M. Significant Improvement of GI Symptom Burden in African
American Transplant Recipients After Conversion of EC-MPS. Am J Transpl 6 Suppl. 2:514,
August 2006.
7)
Tanriover B, Guay-Woodford LM. Single Nucleotide Polymorphism (SNP) – Based Genome
Scan for a Novel Glomerulocystic Kidney Disease (GCKD) Locus. J Am Soc Nephrol 11:399A,
2000.
8)
Tanriover B, Carlton D, Allon M. Treatment Options for Bacteremia Associated with TunneledCuffed Venous Hemodialysis Catheters. J Am Soc Nephrol 10:219A, 1999.
Bekir Tanriover, M.D.
Curriculum Vitae
Page 6
ORAL PRESENTATIONS
Sociedad de Nefrología e Hipertensión de Puerto Rico, Fajardo, PR
July 24-28, 2008
 Liver/Kidney Transplant: Are Two Really Better than One?
NATCO 2007 Annual Meeting, New York City, August 12-14, 2007
 Liver/Kidney Transplant: Are Two Really Better than One?
 Turkish Overview Regarding Donation and Transplantation
92nd Annual Scientific Assembly of Southern Medical Association;
New Orleans, LA, November 20, 1998
 Pulmonary Arterial Compression Secondary to Mediastinal
Lymphadenopathy of Sarcoidosis Presenting as High-Probability V/Q
Mismatch.
 Massive Hemoptysis Secondary to a Bronchogenic Carcinoma Invading
the Left Pulmonary Artery
CERTIFICATIONS
Qualified for Medical License from the Texas State Board of Medical Examiners
on June 6, 2003, (holding active license)
Qualified for Medical License from the Tennessee State Board of Medical
Examiners on January 6, 2003 (holding active license)
Qualified for Medical License from the Louisiana State Board of Medical
Examiners on July 18, 2000
Qualified for Medical License from the Alabama State Board of Medical
Examiners on July 22, 1998
Qualified for ECFMG Certificate on July 5, 1995
ABIM, Board Certified in Nephrology in November 2000
ABIM, Board Certified in Internal Medicine in August 1999
Bekir Tanriover, M.D.
Curriculum Vitae
Page 7
MEMBERSHIPS
American College of Physician
American Society of Nephrology
American Society of Transplantation